Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports.
Marcatili M, Borgonovo R, Cimminiello N, Cornaggia RD, Casati G, Pellicioli C, Maggioni L, Motta F, Redaelli C, Ledda L, Pozzi FE, Krivosova M, Pagano J, Nava R, Colmegna F, Dakanalis A, Caldiroli A, Capuzzi E, Benatti B, Dell'Osso B, Bertola F, Villa N, Piperno A, Ippolito S, Appollonio I, Sala C, Conti L, Clerici M.
Marcatili M, et al. Among authors: maggioni l.
J Pers Med. 2022 Sep 16;12(9):1524. doi: 10.3390/jpm12091524.
J Pers Med. 2022.
PMID: 36143309
Free PMC article.
This NMDA receptor antagonist has proven to be rapidly effective in the short- and medium-term course of the illness, revealing its potential in targeting response in TRD. ...
This NMDA receptor antagonist has proven to be rapidly effective in the short- and medium-term course of the illness, revealing its p …